Citations

Mayo Clinic

Showing 10 of 108599 citations.

Medication use and microscopic colitis: a multicentre retrospective cohort study
Zylberberg, Haley M. , Kamboj, Amrit K. , Cuir, Nicole De, Lane, Conor M. , Khanna, Sahil , Pardi, Darrell S. , Lebwohl, Benjamin

Alimentary Pharmacology & Therapeutics | September 1, 2023 | Volume: 53 | Issue: 11 | Pages: 1209-1215

10.1111/apt.16363 | PMID 33852749 Get It

SummaryBackgroundMedication use has been implicated in the development of microscopic colitis (MC). However, studies have demonstrated inconsistent findings and there exist variations in design.AimTo measure the association between medication use and MC.MethodsPatients who underwent a colonoscopy over a 10‐year period at two academic medical centres (Columbia University Medical Centre and Mayo Clinic) were identified. Cases were patients with biopsy‐proven MC and controls were patients who underwent colonoscopy for evaluation of diarrhoea with biopsies negative for MC. Cases were matched by age, gender and calendar period with up to two controls. Demographics, medication use, smoking history and coeliac disease status were collected. Conditional logistic regression was used with and without adjustment for smoking.ResultsA total of 344 patients with MC were matched to 668 controls. After adjusting for smoking, there was an inverse association between MC and use of proton pump inhibitors (PPIs) (OR 0.64; 95% CI 0.47‐0.87), H2 blockers (OR 0.46; 95% CI 0.24‐0.88) and oral diabetes medications (OR 0.47; 95% CI 0.27‐0.81). There was a positive association with nonsteroidal anti‐inflammatory drug (NSAID) use and MC (OR 1.63; 95% CI 1.12‐2.38).ConclusionsNSAID use was associated with MC, while use of PPIs, H2 blockers and oral diabetes medications were inversely related to MC. Our use of a control group with diarrhoea, as opposed to healthy controls, may have contributed to these inverse associations. Future studies of drug‐induced microscopic colitis should include control groups with diarrhoea, and not only healthy controls.
The dependence of maximum oxygen uptake and utilization (V̇O2max) on hemoglobin‐oxygen affinity and altitude
Webb, Kevin L. , Joyner, Michael J. , Wiggins, Chad C. , Secomb, Timothy W. , Roy, Tuhin K , Wiggins, Chad C , Joyner, Michael J , Secomb, Timothy W , Webb, Kevin L , Roy, Tuhin K.

Physiological Reports | September 1, 2023 | Volume: 11 | Issue: 17 | Pages: No page available

10.14814/phy2.15806 | PMID 37653565 Get It

AbstractOxygen transport from the lungs to peripheral tissue is dependent on the affinity of hemoglobin for oxygen. Recent experimental data have suggested that the maximum human capacity for oxygen uptake and utilization (V̇O2max) at sea level and altitude (~3000 m) is sensitive to alterations in hemoglobin‐oxygen affinity. However, the effect of such alterations on V̇O2max at extreme altitudes remains largely unknown due to the rarity of mutations affecting hemoglobin‐oxygen affinity. This work uses a mathematical model that couples pulmonary oxygen uptake with systemic oxygen utilization under conditions of high metabolic demand to investigate the effect of hemoglobin‐oxygen affinity on V̇O2max as a function of altitude. The model includes the effects of both diffusive and convective limitations on oxygen transport. Pulmonary oxygen uptake is calculated using a spatially‐distributed model that accounts for the effects of hematocrit and hemoglobin‐oxygen affinity. Systemic oxygen utilization is calculated assuming Michaelis–Menten kinetics. The pulmonary and systemic model components are solved iteratively to compute predicted arterial and venous oxygen levels. Values of V̇O2max are predicted for several values of hemoglobin‐oxygen affinity and hemoglobin concentration based on data from humans with hemoglobin mutations. The model predicts that increased hemoglobin‐oxygen affinity leads to increased V̇O2max at altitudes above ~4500 m.
Influence of amyloid and diagnostic syndrome on non‐traditional memory scores in early‐onset Alzheimer's disease
Bushnell, Justin, Hammers, Dustin B. , Aisen, Paul , Dage, Jeffrey L. , Eloyan, Ani , Grinberg, Lea T. , Kirby, Kala, Kramer, Joel H. , Kukull, Walter A. , Joie, Renaud La , Mundada, Nidhi S. , Rumbaugh, Malia, Soleimani‐Meigooni, David N. , Touroutoglou, Alexandra , Vemuri, Prashanthi , Day, Gregory S. , Duara, Ranjan , Graff‐Radford, Neill R. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan , Rogalskı, Emily , Salloway, Steven, Sha, Sharon, Turner, Raymond Scott , Wingo, Thomas S. , Carrillo, María C. , Rabinovici, Gil D. , Apostolova, Liana G. , Clark, David , Vemuri, Prashanthi , Day, Gregory S , La Joie, Renaud , Grinberg, Lea , Rabinovici, Gil D , Wingo, Thomas S , Dage, Jeffrey L , Hammers, Dustin B , Foroud, Tatiana , Iaccarino, Leonardo , Jack, Clifford R. , Koeppe, Robert A. , Murray, Melissa E. , Nudelman, Kelly , Toga, Arthur W. , Atri, Alireza , Duara, Ranjan , Honig, Lawrence S. , Jones, David T. , Masdeu, Joseph C , Musiek, Erik , Salloway, Steve , Sha, Sharon J. , Wolk, David A. , Dickerson, Bradford Clark

Alzheimer's & Dementia | September 1, 2023 | Volume: 19 | Issue: S9 | Pages: No page available

10.1002/alz.13434 | PMID 37653686 Get It

AbstractINTRODUCTIONThe Rey Auditory Verbal Learning Test (RAVLT) is a useful neuropsychological test for describing episodic memory impairment in dementia. However, there is limited research on its utility in early‐onset Alzheimer's disease (EOAD). We assess the influence of amyloid and diagnostic syndrome on several memory scores in EOAD.METHODSWe transcribed RAVLT recordings from 303 subjects in the Longitudinal Early‐Onset Alzheimer's Disease Study. Subjects were grouped by amyloid status and syndrome. Primacy, recency, J‐curve, duration, stopping time, and speed score were calculated and entered into linear mixed effects models as dependent variables.RESULTSCompared with amyloid negative subjects, positive subjects exhibited effects on raw score, primacy, recency, and stopping time. Inter‐syndromic differences were noted with raw score, primacy, recency, J‐curve, and stopping time.DISCUSSIONRAVLT measures are sensitive to the effects of amyloid and syndrome in EOAD. Future work is needed to quantify the predictive value of these scores.Highlights RAVLT patterns characterize various presentations of EOAD and EOnonAD Amyloid impacts raw score, primacy, recency, and stopping time Timing‐based scores add value over traditional count‐based scores
Trends in cardiovascular death related to mechanical complications of cardiac electronic devices in the United States from 1999 to 2020
Tan, Min Choon , Yeo, Yong Hao , San, Boon Jian , Tan, Jian Liang , Yeo, Yong Hao , Tan, Min C

International Journal of Arrhythmia | August 31, 2023 | Volume: 24 | Issue: 1 | Pages: No page available

10.1186/s42444-023-00101-6 Get It

Clinical Image: Scleral melt in granulomatosis with polyangiitis
Kaymakci, Mahmut , Koster, Matthew J. , Kaymakci, Mahmut S , Elfishawi, Mohanad M, Koster, Matthew J , Elfishawi, Mohanad , Warrington, Kenneth J.

ACR Open Rheumatology | August 31, 2023 | Volume: 6 | Issue: 1 | Pages: 3-3

10.1002/acr2.11607 | PMID 37652888 Get It

Ultrasound-guided costovertebral joint injection—technique description and fluoroscopy and computerized tomography combined controlled cadaveric feasibility study
Ferreira‐Silva, Nuno , Worthy, Lucy , Ribas, Rita, Ferreira‐Dos‐Santos, Guilherme , Hurdle, Mark Friedrich B., Bestic, Joseph, Ferreira-Silva, Nuno , Bestic, Joseph M.

Pain Medicine | August 31, 2023 | Volume: 25 | Issue: 1 | Pages: 8-12

10.1093/pm/pnad123 | PMID 37656943 Get It

Abstract Objectives To describe and assess the feasibility of an ultrasound-guided technique for intra-articular injection of the costovertebral joints, in an unembalmed cadaveric specimen, utilizing fluoroscopy and cone beam computerized tomography for confirmation of contrast spread and needle tip position, respectively. Methodology A single unembalmed cadaveric specimen was obtained. A single interventionist performed the placement of the needles under ultrasound guidance. Contrast dye was then injected through each of the needles under real-time fluoroscopy. Finally, the specimen was submitted to a cone beam computerized tomography with 3-dimensional acquisition and multiplanar reformatting to assess final needle tip position relative to the costovertebral joints. Results In total, 18 spinal needles were placed under ultrasound guidance. Fluoroscopy showed 4 distinct patterns of contrast spread: intra-articular in the costovertebral joint (13 levels in total), epidural (1 level), intra-articular in the facet joint of the target level (3 levels), and undetermined (1 level). Cone-beam computerized tomography confirmed 13 out of 18 needles to be adequately placed in the costovertebral joints (72% of the total) and 5 out of the 18 needles to be misplaced: 3 needles were placed in the facet joint of the target level, and 2 needles were placed in the epidural space. Conclusions This study suggests that, when performed by experienced interventionists, this technique has an accuracy rate of 72%. Further studies are warranted before these results can be extrapolated to daily clinical practice.
Teaching NeuroImage: Pachymeningitis and Aortitis as the Initial Presentation of Granulomatosis With Polyangiitis
Li, Xiaoyang , Stitt, Derek , Dubey, Divyanshu , Carabenciov, Ivan D. , Dubey, Divyanshu , Lanzino, Giuseppe , Giannini, Caterina

Neurology | August 31, 2023 | Volume: 101 | Issue: 21 | Pages: 979-980

10.1212/wnl.0000000000207762 | PMID 37652705 Get It

Harassment in the headache field: a global web-based cross-sectional survey
Boer, Irene de , Buse, Dawn C. , Tassorelli, Cristina , Pozo‐Rosich, Patricia , Forum, on behalf of the International Headache Society Women’s Leadership, de Boer, Irene , Tassorelli, Cristina , Pozo-Rosich, Patricia , Ambrosini, Anna , Singh, Rashmi B. Halker , Baykan, Betül , Jensen, Rigmor , Terwindt, Gisela M. , Forum, on behalf of the International Headache Society Women’s Leadership

Cephalalgia | August 31, 2023 | Volume: 43 | Issue: 8 | Pages: No page available

10.1177/03331024231193099 | PMID 37652444 Get It

Background Matters of workplace harassment are an important issue. This issue needs to be recognized and studied to prevent occurrences. These important sensitive areas of effective workplace management are increasingly gaining more interest. We aimed to identify the prevalence of workplace sexual, verbal and physical harassment among headache professionals. Methods We adopted a cross‑sectional exploratory survey approach with quantitative design. The survey was distributed electronically among headache healthcare and research professionals globally through the International Headache Society (IHS). Results Data were obtained from 579 respondents (55.3%; 320/579 women). A large percentage of respondents (46.6%; 270/579) had experienced harassment; specifically, 16.1% (93/578) reported sexual harassment, 40.4% (234/579) verbal harassment and 5.5% (32/579) physical harassment. Women were almost seven times more likely to experience sexual harassment compared to men (odds ratio = 6.8; 95% confidence interval = 3.5–13.2). Although women did also more frequently report other types of harassment, this was not statistically significant (odds ratio = 1.4; 95% confidence interval = 1.0–2.0). Conclusions Lifetime exposure to workplace harassment is prevalent among headache professionals, especially in women. The present study uncovers a widespread issue and calls for strategies to be implemented for building a healthy and safe workplace environment.
Technical note: Exploring the detectability of coronary calcification using ultra‐high‐resolution photon‐counting‐detector CT
Chang, Shaojie , Ren, Liqiang , Tang, Shanshan , Marsh, Jeffrey F., Hsieh, Scott S. , Hsieh, Scott, McCollough, Cynthia H. , Leng, Shuai

Medical Physics | August 31, 2023 | Volume: 50 | Issue: 11 | Pages: 6836-6843

10.1002/mp.16712 | PMID 37650788 Get It

AbstractBackgroundCoronary calcification is a strong indicator of coronary artery disease, and patients with a “zero” coronary calcification score have a much lower risk of future cardiac events than those with even small amounts of calcium. However, false‐negative (incorrect zero scores) may occur if small calcifications are missed at CT due to limited spatial resolution.PurposeTo demonstrate lower limits of detection for coronary calcification using an ultra‐high‐resolution (UHR) mode on a clinical photon‐counting‐detector CT (PCD‐CT), compared to a conventional energy‐integrating‐detector CT (EID‐CT).MethodsChicken eggshell fragments (0.4–0.8 mm) mimicking coronary calcifications were scanned on a clinical PCD‐CT (NAEOTOM Alpha) in UHR mode and a conventional EID‐CT (SOMATOM Force) with matched tube potential and radiation dose levels to the PCD‐CT. PCD‐CT images were reconstructed with a sharp kernel (Qr68) and a quantum iterative algorithm (QIR‐3). Two sets of EID‐CT images were reconstructed: routine clinical kernel (Qr36, ADMIRE‐3) and a sharper kernel (Qr54) with similar noise to PCD‐CT images. With institutional review board approval, in vivo exams performed with the PCD‐CT in UHR mode were compared against patients’ clinical EID‐CT exams. The visibility of calcifications on PCD‐CT and EID‐CT images was assessed and compared qualitatively.ResultsPCD‐CT images visualized all calcified fragments, while EID‐CT failed to detect those below 0.6 mm using a routine protocol. EID‐CT with Qr54 improved visibility but distorted boundaries. Calcifications were less visible on EID‐CT than PCD‐CT as phantom sizes increased. 0.6‐ and 0.7‐mm calcified fragments were barely visible on 35‐ and 40‐cm phantom EID‐CT images. Patient cases showed small calcifications missed on EID‐CT but detected on PCD‐CT.ConclusionAt matched radiation dose, PCD‐CT in UHR mode provided higher spatial resolution and improved the detectability of small calcified fragments for different phantom/patient sizes in comparison to EID‐CT.
Direct early growth response-1 knockdown decreases melanoma viability independent of mitogen-activated extracellular signal-related kinase inhibition
Miley, David R. , Andrews‐Pfannkoch, Cynthia, Pulido, José S. , Erickson, Samantha A., Vile, Richard G. , Fautsch, Michael P. , Marmorstein, Alan D. , Andrews-Pfannkoch, Cynthia M, Marmorstein, Alan D , Dalvin, Lauren A.

Melanoma Research | August 31, 2023 | Volume: 33 | Issue: 6 | Pages: 482-491

10.1097/cmr.0000000000000921 | PMID 37650708 Get It

To investigate downstream molecular changes caused by mitogen-activated protein kinase (MEK) inhibitor treatment and further explore the impact of direct knockdown of early growth response-1 (EGR1) in melanoma cell culture. RNA-sequencing (RNA-Seq) was performed to determine gene expression changes with MEK inhibitor treatment. Treatment with MEK inhibitor (trametinib) was then assessed in two cutaneous (MEL888, MEL624) and one conjunctival (YUARGE 13-3064) melanoma cell line. Direct knockdown of EGR1 was accomplished using lentiviral vectors containing shRNA. Cell viability was measured using PrestoBlueHS Cell Viability Reagent. Total RNA and protein were assessed by qPCR and SimpleWestern. RNA-Seq demonstrated a profound reduction in EGR1 with MEK inhibitor treatment, prompting further study of melanoma cell lines. Following trametinib treatment of melanoma cells, viability was reduced in both cutaneous (MEL888 26%, P < 0.01; MEL624 27%, P < 0.001) and conjunctival (YUARGE 13-3064 33%, P < 0.01) melanoma compared with DMSO control, with confirmed EGR1 knockdown to 0.04-, 0.01-, and 0.16-fold DMSO-treated levels (all P < 0.05) in MEL888, MEL624, and YUARGE 13-3064, respectively. Targeted EGR1 knockdown using shRNA reduced viability in both cutaneous (MEL624 78%, P = 0.05) and conjunctival melanoma (YUARGE-13-3064 67%, P = 0.02). RNA-Sequencing in MEK inhibitor-treated cells identified EGR1 as a candidate effector molecule of interest. In a malignant melanoma cell population, MEK inhibition reduced viability in both cutaneous and conjunctival melanoma with a profound downstream reduction in EGR1 expression. Targeted knockdown of EGR1 reduced both cutaneous and conjunctival melanoma cell viability independent of MEK inhibition, suggesting a key role for EGR1 in melanoma pathobiology.